Investigating the convergence of AD genetics on lipid metabolism and microglia regulation
研究 AD 遗传学对脂质代谢和小胶质细胞调节的趋同性
基本信息
- 批准号:10288338
- 负责人:
- 金额:$ 43.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgonistAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmplifiersAmyloid beta-ProteinAntibodiesBinding ProteinsBiologyCell Culture TechniquesCellsCellular MembraneChemicalsCholesterolCholesterol HomeostasisComplexCorrelation StudiesDiseaseEnvironmentFunctional disorderGenesGeneticGenetic DiseasesGenetic VariationGenetic studyGrantHomeostasisHumanImmuneImmune responseImpaired cognitionIndividualInflammationInflammatoryInflammatory ResponseLeadLinkLipid BindingLipidsMembraneMembrane MicrodomainsMetabolismMethodsMicrogliaModelingMutationNatural ImmunityNervous system structureNeurodegenerative DisordersOutcomePathogenesisPathologyPathway interactionsPhenotypePlayPredispositionProductionProteinsReceptor ActivationReceptor SignalingRegulationRoleSPI1 geneSignal PathwaySignal TransductionSphingolipidsSphingomyelinaseSphingomyelinsSusceptibility GeneToll-like receptorsVariantcholesterol traffickinggenetic variantlipid metabolismmacrophagemonocytepathogenperipheral bloodprotein expressionprotein protein interactionreceptorresponserisk variantsmall hairpin RNAtau Proteins
项目摘要
PROJECT SUMMARY
Genetic studies in Alzheimer’s disease (AD) have clearly indicated a role for microglia, the innate immune
cells of the CNS, in susceptibility to disease. Moreover, microglia are also implicated in lipid metabolism as a
key component of disease mechanism. Microglia are the resident immune cells of the CNS, and are therefore
the primary responders to pathogens. More and more correlation studies implicate pathogens in AD
pathogenesis or progression. However, the association between genetic alterations specific to microglia, toll-like
receptor (TLR) signaling and lipid homeostasis in AD has not been explored in depth. We hypothesize that there
is an interaction between the natural function of the genetically associated microglial proteins, lipids and TLR
stimulation, the basic biology of which has not been fully elucidated in microglia, the innate immune cells that
exist in a lipid rich environment.
Among the many factors involved in the regulation of pathogen response pathways, the lipid composition
of microglia has been shown to contribute significantly to the regulation of inflammatory signaling. Specifically,
cholesterol and sphingomyelin levels have been observed to modulate the expression and distribution of
microglia receptors and their downstream targets. We propose that microglia AD risk variants result in
disturbances in the regulation of sphingolipid and cholesterol, that in turn, cause the dysregulation of
TLR responses and inflammatory phenotypes. We will investigate this hypothesis by examining the effects
of microglia AD susceptibility alleles on sphingolipid regulation and lipid raft turnover in a cell culture microglial
model. We will also assess the role of sphingolipids in the regulation of microglial signaling via TLR and
genetically associated proteins in our microglia model.
Results from this proposal will help understand the crosstalk between genetics, TLR-regulation and
sphingolipid metabolism and underlying mechanisms by which a microglia induces inflammation through
modulation of its membrane in the context of AD.
项目概要
阿尔茨海默氏病 (AD) 的遗传学研究清楚地表明了小胶质细胞(先天免疫)的作用
此外,小胶质细胞还与脂质代谢有关。
小胶质细胞是中枢神经系统的常驻免疫细胞,因此是疾病机制的关键组成部分。
越来越多的相关研究表明 AD 中存在病原体。
然而,小胶质细胞特有的遗传改变之间的关联,类似于Toll。
受体(TLR)信号传导和 AD 中的脂质稳态尚未得到深入研究。
是遗传相关的小胶质细胞蛋白、脂质和 TLR 的自然功能之间的相互作用
刺激,其基本生物学在小胶质细胞中尚未完全阐明,小胶质细胞是先天免疫细胞,
存在于富含脂质的环境中。
在参与病原体反应途径调节的众多因素中,脂质成分
小胶质细胞已被证明对炎症信号的调节有显着贡献。
已观察到胆固醇和鞘磷脂水平可调节
我们认为小胶质细胞受体及其下游靶点会导致 AD 风险变异。
鞘脂和胆固醇的调节紊乱,进而导致
我们将通过检查其影响来研究这一假设。
小胶质细胞 AD 易感性等位基因对细胞培养小胶质细胞中鞘脂调节和筏脂质周转的影响
我们还将评估鞘脂通过 TLR 调节小胶质细胞信号传导的作用。
我们的小胶质细胞模型中的遗传相关蛋白质。
该提案的结果将有助于理解遗传学、TLR 调节和
鞘脂代谢和小胶质细胞通过诱导炎症的潜在机制
AD 背景下对其膜的调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Estela Area Gomez其他文献
Estela Area Gomez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Estela Area Gomez', 18)}}的其他基金
Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's disease
阿尔茨海默病中的内质网线粒体膜
- 批准号:
9484212 - 财政年份:2014
- 资助金额:
$ 43.12万 - 项目类别:
Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's disease
阿尔茨海默病中的内质网线粒体膜
- 批准号:
8767203 - 财政年份:2014
- 资助金额:
$ 43.12万 - 项目类别:
相似国自然基金
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于纳米铝乳剂和模式识别受体激动剂的复合型佐剂研究
- 批准号:82341043
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡瓦胡椒中选择性大麻素2型受体激动剂的发现及其抗骨质疏松作用研究
- 批准号:82360684
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Validation of Platelet Expression of FcɣRIIa as a Precision Tool
FcÉRIIa 的血小板表达作为精密工具的验证
- 批准号:
10682562 - 财政年份:2022
- 资助金额:
$ 43.12万 - 项目类别:
Validation of Platelet Expression of FcɣRIIa as a Precision Tool
FcÉRIIa 的血小板表达作为精密工具的验证
- 批准号:
10682562 - 财政年份:2022
- 资助金额:
$ 43.12万 - 项目类别:
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation
在 2 型糖尿病和心力衰竭的新治疗时代优化老年人护理:通过新方法和证据三角测量加强因果推理
- 批准号:
10673040 - 财政年份:2022
- 资助金额:
$ 43.12万 - 项目类别:
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation
在 2 型糖尿病和心力衰竭的新治疗时代优化老年人护理:通过新方法和证据三角测量加强因果推理
- 批准号:
10449576 - 财政年份:2022
- 资助金额:
$ 43.12万 - 项目类别:
Brain-cell penetrating antibodies for treatment of progressive multiple sclerosis
用于治疗进行性多发性硬化症的脑细胞穿透抗体
- 批准号:
10322911 - 财政年份:2021
- 资助金额:
$ 43.12万 - 项目类别: